Global Antivenom Serum Market Insights and Forecast to 2026
- BMR3911209
- 117 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Antivenom Serum was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Antivenom Serum is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Antivenom Serum market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antivenom Serum market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Antivenom Serum industry.
Global Antivenom Serum Scope and Segment
Antivenom Serum market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antivenom Serum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Merck
Summerland Serums (AU)
Haffkine Bio Pharmaceutical
MicroPharm
CSL (AU)
SAVP
Flynn Pharma
Serum
Antivenom Serum Breakdown Data by Type
Humans
Animals
Antivenom Serum Breakdown Data by Application
Monovalent
Polyvalent
Regional and Country-level Analysis
The Antivenom Serum market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antivenom Serum market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Antivenom Serum Market Share Analysis
1.1 Antivenom Serum Product Introduction
1.2 Market Segments
1.3 Key Antivenom Serum Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antivenom Serum Market Size Growth Rate by Type
1.4.2 Humans
1.4.3 Animals
1.5 Market by Application
1.5.1 Global Antivenom Serum Market Size Growth Rate by Application
1.5.2 Monovalent
1.5.3 Polyvalent
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antivenom Serum Market Size, Estimates and Forecasts
2.1.1 Global Antivenom Serum Revenue 2015-2026
2.1.2 Global Antivenom Serum Sales 2015-2026
2.2 Global Antivenom Serum, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antivenom Serum Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antivenom Serum Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antivenom Serum Competitor Landscape by Players
3.1 Antivenom Serum Sales by Manufacturers
3.1.1 Antivenom Serum Sales by Manufacturers (2015-2020)
3.1.2 Antivenom Serum Sales Market Share by Manufacturers (2015-2020)
3.2 Antivenom Serum Revenue by Manufacturers
3.2.1 Antivenom Serum Revenue by Manufacturers (2015-2020)
3.2.2 Antivenom Serum Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antivenom Serum Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antivenom Serum Revenue in 2019
3.2.5 Global Antivenom Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antivenom Serum Price by Manufacturers
3.4 Antivenom Serum Manufacturing Base Distribution, Product Types
3.4.1 Antivenom Serum Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antivenom Serum Product Type
3.4.3 Date of International Manufacturers Enter into Antivenom Serum Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antivenom Serum Market Size by Type (2015-2020)
4.1.1 Global Antivenom Serum Sales by Type (2015-2020)
4.1.2 Global Antivenom Serum Revenue by Type (2015-2020)
4.1.3 Antivenom Serum Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antivenom Serum Market Size Forecast by Type (2021-2026)
4.2.1 Global Antivenom Serum Sales Forecast by Type (2021-2026)
4.2.2 Global Antivenom Serum Revenue Forecast by Type (2021-2026)
4.2.3 Antivenom Serum Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antivenom Serum Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antivenom Serum Market Size by Application (2015-2020)
5.1.1 Global Antivenom Serum Sales by Application (2015-2020)
5.1.2 Global Antivenom Serum Revenue by Application (2015-2020)
5.1.3 Antivenom Serum Price by Application (2015-2020)
5.2 Antivenom Serum Market Size Forecast by Application (2021-2026)
5.2.1 Global Antivenom Serum Sales Forecast by Application (2021-2026)
5.2.2 Global Antivenom Serum Revenue Forecast by Application (2021-2026)
5.2.3 Global Antivenom Serum Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antivenom Serum by Country
6.1.1 North America Antivenom Serum Sales by Country
6.1.2 North America Antivenom Serum Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antivenom Serum Market Facts & Figures by Type
6.3 North America Antivenom Serum Market Facts & Figures by Application
7 Europe
7.1 Europe Antivenom Serum by Country
7.1.1 Europe Antivenom Serum Sales by Country
7.1.2 Europe Antivenom Serum Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antivenom Serum Market Facts & Figures by Type
7.3 Europe Antivenom Serum Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antivenom Serum by Region
8.1.1 Asia Pacific Antivenom Serum Sales by Region
8.1.2 Asia Pacific Antivenom Serum Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antivenom Serum Market Facts & Figures by Type
8.3 Asia Pacific Antivenom Serum Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antivenom Serum by Country
9.1.1 Latin America Antivenom Serum Sales by Country
9.1.2 Latin America Antivenom Serum Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antivenom Serum Market Facts & Figures by Type
9.3 Central & South America Antivenom Serum Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antivenom Serum by Country
10.1.1 Middle East and Africa Antivenom Serum Sales by Country
10.1.2 Middle East and Africa Antivenom Serum Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antivenom Serum Market Facts & Figures by Type
10.3 Middle East and Africa Antivenom Serum Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Antivenom Serum Products Offered
11.1.5 Merck Related Developments
11.2 Summerland Serums (AU)
11.2.1 Summerland Serums (AU) Corporation Information
11.2.2 Summerland Serums (AU) Description and Business Overview
11.2.3 Summerland Serums (AU) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Summerland Serums (AU) Antivenom Serum Products Offered
11.2.5 Summerland Serums (AU) Related Developments
11.3 Haffkine Bio Pharmaceutical
11.3.1 Haffkine Bio Pharmaceutical Corporation Information
11.3.2 Haffkine Bio Pharmaceutical Description and Business Overview
11.3.3 Haffkine Bio Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Haffkine Bio Pharmaceutical Antivenom Serum Products Offered
11.3.5 Haffkine Bio Pharmaceutical Related Developments
11.4 MicroPharm
11.4.1 MicroPharm Corporation Information
11.4.2 MicroPharm Description and Business Overview
11.4.3 MicroPharm Sales, Revenue and Gross Margin (2015-2020)
11.4.4 MicroPharm Antivenom Serum Products Offered
11.4.5 MicroPharm Related Developments
11.5 CSL (AU)
11.5.1 CSL (AU) Corporation Information
11.5.2 CSL (AU) Description and Business Overview
11.5.3 CSL (AU) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CSL (AU) Antivenom Serum Products Offered
11.5.5 CSL (AU) Related Developments
11.6 SAVP
11.6.1 SAVP Corporation Information
11.6.2 SAVP Description and Business Overview
11.6.3 SAVP Sales, Revenue and Gross Margin (2015-2020)
11.6.4 SAVP Antivenom Serum Products Offered
11.6.5 SAVP Related Developments
11.7 Flynn Pharma
11.7.1 Flynn Pharma Corporation Information
11.7.2 Flynn Pharma Description and Business Overview
11.7.3 Flynn Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Flynn Pharma Antivenom Serum Products Offered
11.7.5 Flynn Pharma Related Developments
11.8 Serum
11.8.1 Serum Corporation Information
11.8.2 Serum Description and Business Overview
11.8.3 Serum Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Serum Antivenom Serum Products Offered
11.8.5 Serum Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Antivenom Serum Products Offered
11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antivenom Serum Market Estimates and Projections by Region
12.1.1 Global Antivenom Serum Sales Forecast by Regions 2021-2026
12.1.2 Global Antivenom Serum Revenue Forecast by Regions 2021-2026
12.2 North America Antivenom Serum Market Size Forecast (2021-2026)
12.2.1 North America: Antivenom Serum Sales Forecast (2021-2026)
12.2.2 North America: Antivenom Serum Revenue Forecast (2021-2026)
12.2.3 North America: Antivenom Serum Market Size Forecast by Country (2021-2026)
12.3 Europe Antivenom Serum Market Size Forecast (2021-2026)
12.3.1 Europe: Antivenom Serum Sales Forecast (2021-2026)
12.3.2 Europe: Antivenom Serum Revenue Forecast (2021-2026)
12.3.3 Europe: Antivenom Serum Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antivenom Serum Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antivenom Serum Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antivenom Serum Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antivenom Serum Market Size Forecast by Region (2021-2026)
12.5 Latin America Antivenom Serum Market Size Forecast (2021-2026)
12.5.1 Latin America: Antivenom Serum Sales Forecast (2021-2026)
12.5.2 Latin America: Antivenom Serum Revenue Forecast (2021-2026)
12.5.3 Latin America: Antivenom Serum Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antivenom Serum Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antivenom Serum Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antivenom Serum Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antivenom Serum Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antivenom Serum Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antivenom Serum Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antivenom Serum Market Segments
Table 2. Ranking of Global Top Antivenom Serum Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antivenom Serum Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Humans
Table 5. Major Manufacturers of Animals
Table 6. Global Antivenom Serum Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Antivenom Serum Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Antivenom Serum Sales by Regions 2015-2020 (K Doses)
Table 9. Global Antivenom Serum Sales Market Share by Regions (2015-2020)
Table 10. Global Antivenom Serum Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antivenom Serum Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Antivenom Serum Sales Share by Manufacturers (2015-2020)
Table 13. Global Antivenom Serum Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Antivenom Serum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antivenom Serum as of 2019)
Table 15. Antivenom Serum Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Antivenom Serum Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Antivenom Serum Price (2015-2020) (USD/Dose)
Table 18. Antivenom Serum Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Antivenom Serum Product Type
Table 20. Date of International Manufacturers Enter into Antivenom Serum Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 23. Global Antivenom Serum Sales Share by Type (2015-2020)
Table 24. Global Antivenom Serum Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Antivenom Serum Revenue Share by Type (2015-2020)
Table 26. Antivenom Serum Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 28. Global Antivenom Serum Sales Share by Application (2015-2020)
Table 29. North America Antivenom Serum Sales by Country (2015-2020) (K Doses)
Table 30. North America Antivenom Serum Sales Market Share by Country (2015-2020)
Table 31. North America Antivenom Serum Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Antivenom Serum Revenue Market Share by Country (2015-2020)
Table 33. North America Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 34. North America Antivenom Serum Sales Market Share by Type (2015-2020)
Table 35. North America Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 36. North America Antivenom Serum Sales Market Share by Application (2015-2020)
Table 37. Europe Antivenom Serum Sales by Country (2015-2020) (K Doses)
Table 38. Europe Antivenom Serum Sales Market Share by Country (2015-2020)
Table 39. Europe Antivenom Serum Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Antivenom Serum Revenue Market Share by Country (2015-2020)
Table 41. Europe Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 42. Europe Antivenom Serum Sales Market Share by Type (2015-2020)
Table 43. Europe Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 44. Europe Antivenom Serum Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Antivenom Serum Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Antivenom Serum Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Antivenom Serum Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Antivenom Serum Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Antivenom Serum Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Antivenom Serum Sales Market Share by Application (2015-2020)
Table 53. Latin America Antivenom Serum Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Antivenom Serum Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Antivenom Serum Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Antivenom Serum Revenue Market Share by Country (2015-2020)
Table 57. Latin America Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Antivenom Serum Sales Market Share by Type (2015-2020)
Table 59. Latin America Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Antivenom Serum Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Antivenom Serum Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Antivenom Serum Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Antivenom Serum Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Antivenom Serum Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antivenom Serum Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Antivenom Serum Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Antivenom Serum Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Antivenom Serum Sales Market Share by Application (2015-2020)
Table 69. Merck Corporation Information
Table 70. Merck Description and Major Businesses
Table 71. Merck Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. Merck Product
Table 73. Merck Recent Development
Table 74. Summerland Serums (AU) Corporation Information
Table 75. Summerland Serums (AU) Description and Major Businesses
Table 76. Summerland Serums (AU) Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Summerland Serums (AU) Product
Table 78. Summerland Serums (AU) Recent Development
Table 79. Haffkine Bio Pharmaceutical Corporation Information
Table 80. Haffkine Bio Pharmaceutical Description and Major Businesses
Table 81. Haffkine Bio Pharmaceutical Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Haffkine Bio Pharmaceutical Product
Table 83. Haffkine Bio Pharmaceutical Recent Development
Table 84. MicroPharm Corporation Information
Table 85. MicroPharm Description and Major Businesses
Table 86. MicroPharm Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. MicroPharm Product
Table 88. MicroPharm Recent Development
Table 89. CSL (AU) Corporation Information
Table 90. CSL (AU) Description and Major Businesses
Table 91. CSL (AU) Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. CSL (AU) Product
Table 93. CSL (AU) Recent Development
Table 94. SAVP Corporation Information
Table 95. SAVP Description and Major Businesses
Table 96. SAVP Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. SAVP Product
Table 98. SAVP Recent Development
Table 99. Flynn Pharma Corporation Information
Table 100. Flynn Pharma Description and Major Businesses
Table 101. Flynn Pharma Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Flynn Pharma Product
Table 103. Flynn Pharma Recent Development
Table 104. Serum Corporation Information
Table 105. Serum Description and Major Businesses
Table 106. Serum Antivenom Serum Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Serum Product
Table 108. Serum Recent Development
Table 109. Global Antivenom Serum Sales Forecast by Regions (2021-2026) (K Doses)
Table 110. Global Antivenom Serum Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Antivenom Serum Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Antivenom Serum Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Antivenom Serum Sales Forecast by Country (2021-2026) (K Doses)
Table 114. North America: Antivenom Serum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Antivenom Serum Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Europe: Antivenom Serum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Antivenom Serum Sales Forecast by Region (2021-2026) (K Doses)
Table 118. Asia Pacific: Antivenom Serum Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Antivenom Serum Sales Forecast by Country (2021-2026) (K Doses)
Table 120. Latin America: Antivenom Serum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Antivenom Serum Sales Forecast by Country (2021-2026) (K Doses)
Table 122. Middle East and Africa: Antivenom Serum Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Antivenom Serum Players
Table 127. Antivenom Serum Customers List
Table 128. Antivenom Serum Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Serum Product Picture
Figure 2. Global Antivenom Serum Sales Market Share by Type in 2020 & 2026
Figure 3. Humans Product Picture
Figure 4. Animals Product Picture
Figure 5. Global Antivenom Serum Sales Market Share by Application in 2020 & 2026
Figure 6. Monovalent
Figure 7. Polyvalent
Figure 8. Antivenom Serum Report Years Considered
Figure 9. Global Antivenom Serum Market Size 2015-2026 (US$ Million)
Figure 10. Global Antivenom Serum Sales 2015-2026 (K Doses)
Figure 11. Global Antivenom Serum Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Antivenom Serum Sales Market Share by Region (2015-2020)
Figure 13. Global Antivenom Serum Sales Market Share by Region in 2019
Figure 14. Global Antivenom Serum Revenue Market Share by Region (2015-2020)
Figure 15. Global Antivenom Serum Revenue Market Share by Region in 2019
Figure 16. Global Antivenom Serum Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Antivenom Serum Revenue in 2019
Figure 18. Antivenom Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antivenom Serum Sales Market Share by Type (2015-2020)
Figure 20. Global Antivenom Serum Sales Market Share by Type in 2019
Figure 21. Global Antivenom Serum Revenue Market Share by Type (2015-2020)
Figure 22. Global Antivenom Serum Revenue Market Share by Type in 2019
Figure 23. Global Antivenom Serum Market Share by Price Range (2015-2020)
Figure 24. Global Antivenom Serum Sales Market Share by Application (2015-2020)
Figure 25. Global Antivenom Serum Sales Market Share by Application in 2019
Figure 26. Global Antivenom Serum Revenue Market Share by Application (2015-2020)
Figure 27. Global Antivenom Serum Revenue Market Share by Application in 2019
Figure 28. North America Antivenom Serum Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Antivenom Serum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Antivenom Serum Sales Market Share by Country in 2019
Figure 31. North America Antivenom Serum Revenue Market Share by Country in 2019
Figure 32. U.S. Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Antivenom Serum Market Share by Type in 2019
Figure 37. North America Antivenom Serum Market Share by Application in 2019
Figure 38. Europe Antivenom Serum Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Antivenom Serum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Antivenom Serum Sales Market Share by Country in 2019
Figure 41. Europe Antivenom Serum Revenue Market Share by Country in 2019
Figure 42. Germany Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Antivenom Serum Market Share by Type in 2019
Figure 53. Europe Antivenom Serum Market Share by Application in 2019
Figure 54. Asia Pacific Antivenom Serum Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Antivenom Serum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Antivenom Serum Sales Market Share by Region in 2019
Figure 57. Asia Pacific Antivenom Serum Revenue Market Share by Region in 2019
Figure 58. China Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Antivenom Serum Market Share by Type in 2019
Figure 81. Asia Pacific Antivenom Serum Market Share by Application in 2019
Figure 82. Latin America Antivenom Serum Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Antivenom Serum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Antivenom Serum Sales Market Share by Country in 2019
Figure 85. Latin America Antivenom Serum Revenue Market Share by Country in 2019
Figure 86. Mexico Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Antivenom Serum Market Share by Type in 2019
Figure 93. Latin America Antivenom Serum Market Share by Application in 2019
Figure 94. Middle East and Africa Antivenom Serum Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Antivenom Serum Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Antivenom Serum Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Antivenom Serum Revenue Market Share by Country in 2019
Figure 98. Turkey Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Antivenom Serum Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Antivenom Serum Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Antivenom Serum Market Share by Type in 2019
Figure 105. Middle East and Africa Antivenom Serum Market Share by Application in 2019
Figure 106. North America Antivenom Serum Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 107. North America Antivenom Serum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Antivenom Serum Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. Europe Antivenom Serum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Antivenom Serum Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Asia Pacific Antivenom Serum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Antivenom Serum Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Latin America Antivenom Serum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Antivenom Serum Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Middle East and Africa Antivenom Serum Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
